Literature DB >> 2429989

Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence.

E Reiss, L de Repentigny, R J Kuykendall, A W Carter, R Galindo, P Auger, S L Bragg, L Kaufman.   

Abstract

Three strains of mice were immunized with Candida tropicalis cell walls, and antibodies against mannan were detected by indirect enzyme immunoassay (EIA) in 3 of 9 BALB/c mice, 4 of 11 C57BL/6 mice, and 4 of 8 CFW mice. Responding mice produced immunoglobulin M (IgM), but IgG was not detected in their sera. Fusion of the high-responder BALB/c mouse with a plasmacytoma cell line resulted in 41 clones secreting antimannan monoclonal antibodies (MAbs). Four clones selected for propagation included one IgM and one IgG MAb that reacted with mannans of Candida albicans serotypes A and B and of C. tropicalis and two IgM MAbs specific for an epitope only in the mannans of C. albicans serotype A and C. tropicalis. One of the IgM MAbs, CB6, was an effective substitute for rabbit antibodies in the double-antibody sandwich EIA to detect antigenemia produced in rabbits infected with C. albicans A or C. tropicalis. It could function either as the peroxidase-conjugated indicator antibody or as the capture antibody. Two MAbs, CB6 (C. tropicalis and C. albicans A specific) and AC3 (C. tropicalis and C. albicans A and B specific), functioned in place of polyclonal antisera in the serotyping of C. albicans by immunofluorescence. There was 95.8% agreement in the results of serotyping using MAbs as reagents compared with rabbit antisera. Competitive inhibition in EIA between CB6 and monospecific antisera against C. albicans factors 1, 4, and 6 indicated that CB6 binds to an epitope which is probably factor 6. Serologic similarity between factor 4 and the binding site of MAb AC3 was also determined.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429989      PMCID: PMC269031          DOI: 10.1128/jcm.24.5.796-802.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  POLYSACCHARIDE ANTIGENS OF CANDIDA CELL WALL.

Authors:  D F SUMMERS; A P GROLLMAN; H F HASENCLEVER
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Relationship between phosphate content and serological activities of the mannans of Candida albicans strains NIH A-207, NIH B-792, and J-1012.

Authors:  Y Okubo; Y Honma; S Suzuki
Journal:  J Bacteriol       Date:  1979-01       Impact factor: 3.490

4.  Characterization of the carbohydrate fragments obtained from Saccharomyces cerevisiae mannan by alkaline degradation.

Authors:  T Nakajima; C E Ballou
Journal:  J Biol Chem       Date:  1974-12-10       Impact factor: 5.157

5.  Structure and biosynthesis of the mannan component of the yeast cell envelope.

Authors:  C Ballou
Journal:  Adv Microb Physiol       Date:  1976       Impact factor: 3.517

6.  A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine.

Authors:  P Auger; C Dumas; J Joly
Journal:  J Infect Dis       Date:  1979-05       Impact factor: 5.226

7.  Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.

Authors:  A Fischer; J J Ballet; C Griscelli
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

8.  Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls.

Authors:  E Reiss; S H Stone; H F Hasenclever
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

9.  Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients.

Authors:  P F Lehmann; E Reiss
Journal:  Mycopathologia       Date:  1980-03-17       Impact factor: 2.574

10.  Detection of Candida albicans mannan by immunodiffusion, counterimmunoelectrophoresis, and enzyme-linked immunoassay.

Authors:  P F Lehmann; E Reiss
Journal:  Mycopathologia       Date:  1980-03-17       Impact factor: 2.574

View more
  20 in total

Review 1.  Cytological immunodetection of yeast glycoprotein secretion.

Authors:  J C Cailliez; D Poulain; D W Mackenzie; L Polonelli
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 2.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

3.  Rapid detection of vaginal Candida species by newly developed immunochromatography.

Authors:  Hidehito Matsui; Hideaki Hanaki; Kengo Takahashi; Akihiko Yokoyama; Taiji Nakae; Keisuke Sunakawa; Satoshi Omura
Journal:  Clin Vaccine Immunol       Date:  2009-08-05

4.  Production and characterization of monoclonal antibodies to cell wall antigens of Aspergillus fumigatus.

Authors:  L Ste-Marie; S Sénéchal; M Boushira; S Garzon; H Strykowski; L Pedneault; L de Repentigny
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

5.  Production and characterization of murine monoclonal antibodies to Histoplasma capsulatum yeast cell antigens.

Authors:  S M Kamel; L J Wheat; M L Garten; M S Bartlett; M R Tansey; R P Tewari
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 6.  Serological techniques for diagnosis of fungal infection.

Authors:  L de Repentigny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

7.  Comparison between methods for serotyping of Candida albicans produces discrepancies in results.

Authors:  D L Brawner
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

8.  Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.

Authors:  D L Brawner; J E Cutler
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

9.  Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis.

Authors:  F De Bernardis; C Girmenia; M Boccanera; D Adriani; P Martino; A Cassone
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

10.  Characterization of mutant strains of Candida albicans deficient in expression of a surface determinant.

Authors:  W L Chaffin; B Collins; J N Marx; G T Cole; K J Morrow
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.